The remodeling of glucose metabolism in pathogenic CD8+ T cells can reduce the deleterious inflammatory and cytolytic effects in autoimmune diseases such as rheumatoid arthritis [28]. The gene discussed is CD8A; the disease is rheumatoid arthritis.